BIOSCRIP, INC. AND SUBSIDIARIES UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATIONBioScrip, Inc. • May 10th, 2012 • Retail-drug stores and proprietary stores
On February 1, 2012, the Company entered into a Community Pharmacy and Mail Business Purchase Agreement, as amended by Amendment No. 1 dated May 4, 2012 (as amended, the “Asset Purchase Agreement”), by and among Walgreen Co. and certain subsidiaries (collectively, the “Buyers”) and the Company and certain subsidiaries with respect to the sale of certain assets, rights and properties (the “Pharmacy Services Asset Sale”) relating to the Company’s traditional and specialty pharmacy mail operations and community retail pharmacy stores.
AMENDMENT NO.1 TO COMMUNITY PHARMACY AND MAIL BUSINESS PURCHASE AGREEMENTCommunity Pharmacy and Mail Business Purchase Agreement • May 10th, 2012 • BioScrip, Inc. • Retail-drug stores and proprietary stores • Delaware
This Amendment No. 1 to Community Pharmacy and Mail Business Purchase Agreement dated as of May 4, 2012 (this “Amendment”) is entered into by and by and among Walgreen Co., an Illinois corporation (“Parent”), Walgreens Mail Service, Inc., an Illinois corporation (“Buyer 1”), Walgreens Specialty Pharmacy, LLC, a Delaware limited liability company (“Buyer 2”), and Walgreen Eastern Co., Inc., a New York corporation (“Buyer 3” and, together with Parent, Buyer 1 and Buyer 2, the “Buyers”), BioScrip, Inc., a Delaware corporation (“BioScrip”), BioScrip Pharmacy (NY), Inc., a New York corporation, BioScrip Pharmacy Services, Inc., an Ohio corporation, BioScrip Pharmacy, Inc., a Minnesota corporation, Bradhurst Specialty Pharmacy, Inc., a New York corporation, BioScrip Infusion Services, Inc., a California corporation and Natural Living Inc., a New York corporation (together with BioScrip, the “Selling Parties”). Capitalized terms not otherwise defined herein shall have the meaning set forth in
